| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALL | Common Stock | Options Exercise | $70.6K | +700 | +3.86% | $100.80 | 18.8K | Feb 10, 2025 | Direct | |
| transaction | ALL | Common Stock | Options Exercise | $2.44M | +19.7K | +104.55% | $124.26 | 38.5K | Feb 10, 2025 | Direct | |
| transaction | ALL | Common Stock | Options Exercise | $1.02M | +9.73K | +25.28% | $105.08 | 48.2K | Feb 10, 2025 | Direct | |
| transaction | ALL | Common Stock | Options Exercise | $1.23M | +10K | +20.74% | $122.64 | 58.2K | Feb 10, 2025 | Direct | |
| transaction | ALL | Common Stock | Sale | -$5.08M | -27.3K | -46.92% | $186.03 | 30.9K | Feb 10, 2025 | Direct | F1 |
| transaction | ALL | Common Stock | Sale | -$1.61M | -8.59K | -27.8% | $187.20 | 22.3K | Feb 10, 2025 | Direct | F2 |
| transaction | ALL | Common Stock | Sale | -$499K | -2.65K | -11.9% | $188.14 | 19.7K | Feb 10, 2025 | Direct | F3 |
| transaction | ALL | Common Stock | Sale | -$291K | -1.54K | -7.84% | $188.99 | 18.1K | Feb 10, 2025 | Direct | F4 |
| holding | ALL | Common Stock | 7.48K | Feb 10, 2025 | By 401(k) Plan |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALL | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -700 | -100% | $0.00 | 0 | Feb 10, 2025 | Common Stock | 700 | $100.80 | Direct | |
| transaction | ALL | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -19.7K | -100% | $0.00 | 0 | Feb 10, 2025 | Common Stock | 19.7K | $124.26 | Direct | |
| transaction | ALL | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -9.73K | -100% | $0.00 | 0 | Feb 10, 2025 | Common Stock | 9.73K | $105.08 | Direct | |
| transaction | ALL | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -10K | -43.71% | $0.00 | 12.9K | Feb 10, 2025 | Common Stock | 10K | $122.64 | Direct | F5 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $185.640 to $186.630. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. |
| F2 | Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $186.670 to $187.610. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. |
| F3 | Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $187.670 to $188.615. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. |
| F4 | Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $188.830 to $189.740. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. |
| F5 | Stock option award granted on February 17, 2022, for 22,879 shares of common stock vesting in three equal increments. The remaining increment will vest on February 17, 2025. |
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on September 20, 2024.